Accessibility: Skip TopNav
CB-011
CB-011 is a genome-edited allogeneic anti-BCMA CAR-T cell therapy with immune cloaking.
Format
PNG
Source
Caribou Biosciences, Inc.
Downloads
Original
Large
Medium
Small